Oxidation-Driven mtDNA B-Z Transition Activates ZBP1 to Mediate Acetaminophen Hepatotoxicity

This study identifies that oxidative stress-induced B-to-Z transitions in mitochondrial DNA activate ZBP1 signaling to drive acetaminophen hepatotoxicity, and demonstrates that targeting this pathway with the OGG1 activator TH107854 significantly improves survival in mice, even when combined with standard NAC treatment.

The Gist

The Big Picture: A Chemical Overdose and a Hidden Trigger

Imagine your liver is a busy chemical processing plant. Its main job is to clean toxins out of your blood. One of the most common "toxins" it handles is Acetaminophen (APAP), the active ingredient in Tylenol.

Usually, the plant has a safety team (a molecule called Glutathione) that neutralizes the APAP before it causes trouble. But if you take too much APAP, the safety team gets overwhelmed. A toxic byproduct (NAPQI) is created that starts smashing up the plant's internal machinery, specifically the power generators (mitochondria).

For a long time, doctors knew that if you caught this early (within 8 hours), you could save the plant by giving it more safety team members (a drug called NAC). But if you wait too long, the damage becomes irreversible, leading to liver failure and death. The big mystery was: What happens after the 8-hour mark that makes the damage unstoppable?

This paper solves that mystery. It turns out the damage isn't just about broken machinery; it's about a false alarm triggered by a specific type of DNA shape-shifting.

---

The Story: The "Zombie" DNA and the Alarm System

1. The Leak

When the APAP overdose hits, the mitochondria (the power generators) get damaged and start leaking their contents. One of the things that leaks out is mitochondrial DNA (mtDNA). Think of this like a factory leaking its blueprints into the main office floor.

Usually, when blueprints leak out, the security system (the immune system) ignores them because they belong to the factory. But in this case, the leaked DNA is damaged. It has been oxidized (rusty) by the toxic environment.

2. The Shape-Shifter (B-DNA vs. Z-DNA)

DNA usually looks like a standard right-handed spiral staircase. Scientists call this B-DNA. It's the normal, calm shape.

However, when this DNA gets "rusty" (oxidized) from the APAP toxicity, something weird happens. The rusty spots force the DNA to twist into a left-handed spiral. Scientists call this Z-DNA.

• Analogy: Imagine a normal spiral staircase suddenly twisting into a weird, jagged, left-handed corkscrew. It looks so strange that the building's security system thinks it's an intruder.

3. The False Alarm (ZBP1)

The liver has a security guard named ZBP1. Its job is to look for these weird, left-handed "Z-shapes."

• Normally, ZBP1 ignores the standard right-handed DNA.
• But when the rusty DNA twists into the Z-shape, ZBP1 grabs onto it tightly.
• The Mistake: ZBP1 thinks, "Oh no! A foreign invader has twisted our DNA!" It sounds the alarm and orders the cell to commit suicide (a process called apoptosis) to stop the "infection."

The paper proves that the cell isn't dying because the mitochondria are broken; it's dying because the security guard (ZBP1) is panicking over the twisted, rusty DNA.

4. Why the Old Medicine (NAC) Fails Later

The standard treatment, NAC, works by replenishing the safety team (Glutathione) to stop the initial rusting. But once the DNA has already twisted into the Z-shape and the security guard has started the suicide order, adding more safety team members doesn't help. The alarm is already ringing, and the cell is already marching toward death.

---

The Solution: The "De-Rusting" Tool

The researchers found a way to stop the panic. They used a special tool called TH10785.

• What it does: This tool activates an enzyme called OGG1. Think of OGG1 as a mechanic that can go in and fix the "rust" (the 8-oxoG damage) on the DNA.
• The Result: Once the mechanic fixes the rust, the DNA stops being a weird left-handed corkscrew. It relaxes back into its normal, right-handed spiral (B-DNA).
• The Outcome: The security guard (ZBP1) looks at the DNA, sees it's normal again, and stops the alarm. The cell survives.

The Miracle Cure in the Lab

The researchers tested this on mice with a lethal dose of APAP:

1. Standard Treatment (NAC) given late: Only 50% of the mice survived. (The alarm was already ringing).
2. New Treatment (TH10785) given late: 90% survived. (The mechanic fixed the DNA, silencing the alarm).
3. Combination (NAC + TH10785): 100% survived. (The safety team stopped the rusting, AND the mechanic fixed the DNA shape).

Why This Matters

This discovery changes how we think about liver failure. It's not just about "damage"; it's about DNA geometry.

• The Metaphor: It's like a smoke detector. If you burn toast (APAP toxicity), the smoke (oxidative stress) makes the detector (ZBP1) go off. Usually, you just open a window (NAC) to clear the smoke. But if the detector gets stuck in the "ON" position because the smoke changed the shape of the sensor, opening the window won't help. You need a tool to reset the sensor (TH10785).

This paper suggests that for patients who come to the hospital too late for the standard antidote, we might be able to save them by using this new "de-rusting" therapy to stop the false alarm and save the liver cells.

Technical Summary

1. Problem Statement

Acetaminophen (APAP) overdose is a leading cause of acute liver failure (ALF) worldwide. The primary mechanism involves the metabolism of APAP into the toxic metabolite NAPQI, which depletes glutathione (GSH) and causes mitochondrial dysfunction and reactive oxygen species (ROS) overproduction.

• The Clinical Gap: While N-acetylcysteine (NAC) is the standard antidote, it is only effective if administered within 8 hours of overdose. Beyond this window, mitochondrial damage leads to irreversible secondary injury and hepatocyte death that NAC cannot mitigate, often necessitating liver transplantation.
• The Scientific Question: The specific molecular mechanisms driving this secondary, NAC-resistant hepatocyte death remain poorly understood. Specifically, how does cytosolic mitochondrial DNA (mtDNA), released during mitochondrial damage, trigger cell death without activating the canonical cGAS-STING innate immune pathway?

2. Methodology

The study employed a multidisciplinary approach combining in vivo mouse models, in vitro cell cultures, structural biology, and pharmacological interventions.

• Animal Models:
  • Wild-type (WT) and genetically modified mice (KO) were used: Zbp1⁻/⁻, cGAS⁻/⁻, Ripk3⁻/⁻, Mlkl⁻/⁻, and mice expressing ZBP1 Zα domain mutants (ZaMut).
  • APAP Induction: Mice received a lethal (550 mg/kg) or sub-lethal (300 mg/kg) intraperitoneal dose of APAP.
  • Therapeutic Interventions: Mice were treated with NAC (standard of care), TH10785 (an OGG1 agonist), MitoQ (mitochondrial ROS scavenger), or Cyclosporine A (mPTP inhibitor).
• Cell Models:
  • AML12 hepatocytes and primary mouse hepatocytes were treated with APAP (10 mM).
  • Genetic Manipulation: shRNA knockdown of Zbp1, Fen1, and siRNA targeting specific genes; CRISPR/Cas9 or lentiviral generation of KO cell lines.
  • mtDNA Depletion: Cells were treated with Ethidium Bromide (EtBr) to generate $\rho^0$ cells (mtDNA-depleted).
• Molecular & Structural Analyses:
  • DNA Conformation: Used the Z22 antibody (specific for Z-DNA/Z-RNA) and Z-NA specific staining.
  • Biochemical Assays: Electrophoretic Mobility Shift Assays (EMSA) using synthetic 12-bp dGdC duplexes with varying levels of 8-oxoG (0, 1, or 3 substitutions) to test ZBP1 binding.
  • Spectroscopy: Measured A260/A295 absorbance ratios to distinguish B-DNA from Z-DNA conformations under physiological salt conditions.
  • Immunoprecipitation (IP): ZBP1 IP followed by qPCR to identify bound DNA sources (mitochondrial vs. nuclear).
• Pharmacology:
  • TH10785: Used to activate OGG1 (8-oxoguanine DNA glycosylase), the enzyme responsible for repairing 8-oxoG lesions.

3. Key Contributions

1. Identification of a Non-Canonical Pathway: The study establishes that cytosolic mtDNA in APAP toxicity activates ZBP1 (Z-DNA binding protein 1) rather than the canonical cGAS-STING pathway.
2. Discovery of Oxidation-Driven Z-DNA Formation: The authors demonstrate that oxidative stress (specifically 8-oxoG modification) is sufficient to drive the conformational transition of DNA from the canonical right-handed B-form to the left-handed Z-form under physiological salt concentrations, bypassing the need for high-salt conditions typically required for this transition.
3. Mechanistic Link to Cell Death: The study proves that ZBP1 recognizes this oxidized Z-DNA via its Zα domain, triggering caspase-3 dependent apoptosis (not necroptosis or pyroptosis) in hepatocytes.
4. Therapeutic Breakthrough: The identification of TH10785 (OGG1 agonist) as a potent therapeutic agent that reverses the Z-DNA transition and rescues mice from lethal APAP toxicity, even when administered after the NAC window has closed.

4. Key Results

• ZBP1, Not cGAS, Drives APAP Toxicity:

  • APAP treatment caused cytosolic mtDNA leakage.
  • cGAS KO mice showed no protection against APAP-induced liver injury, and cGAMP levels did not rise.
  • In contrast, Zbp1 KO mice exhibited significant protection: reduced serum ALT/AST, decreased necrotic areas, and a survival rate of 60% (vs. 10% in WT) after lethal APAP challenge.
  • ZBP1 activation led to apoptosis (cleaved caspase-3), not necroptosis (no p-MLKL) or pyroptosis (no GSDMD cleavage).

• mtDNA is the Source of Z-DNA:

  • Z-NA signals colocalized with mitochondrial markers (TOM20) and were abolished by DNase I but not RNase A.
  • ZBP1 immunoprecipitation confirmed specific binding to mitochondrial DNA (Nd1/Nd2) but not nuclear DNA.
  • Depletion of mtDNA (via EtBr) prevented Z-DNA formation and subsequent apoptosis.

• Oxidative Stress Induces B-to-Z Transition:

  • APAP induced massive ROS and 8-oxoG accumulation in mtDNA.
  • Synthetic DNA Experiments: Synthetic 12-bp dsDNA with 8-oxoG substitutions shifted from B-form to Z-form at physiological salt (20 mM NaCl), evidenced by a drop in the A260/A295 ratio and specific binding to the ZBP1 Zα domain.
  • The transition was dose-dependent on oxidation levels (3 substitutions > 1 substitution).
  • This transition occurred independently of ZBP1 or ADAR1, proving the chemical modification drives the structural change.

• Therapeutic Efficacy of OGG1 Activation:

  • Mechanism: TH10785 activated OGG1, which removed 8-oxoG lesions, reverting Z-DNA back to B-DNA.
  • In Vitro: TH10785 reduced cytosolic oxidized mtDNA, Z-DNA levels, and apoptosis in AML12 cells.
  • In Vivo (Delayed Treatment):
    • In a lethal APAP model, delayed treatment (10 hours post-overdose) with NAC alone resulted in ~50% mortality.
    • TH10785 monotherapy increased survival to 90%.
    • Combination Therapy (TH10785 + NAC) achieved 100% survival, demonstrating a synergistic effect.

5. Significance

• Paradigm Shift in DNA Sensing: This work redefines the understanding of DNA conformational dynamics, showing that oxidative damage alone can induce Z-DNA formation under physiological conditions, acting as a "danger signal" distinct from viral or bacterial DNA sensing.
• New Therapeutic Window for ALF: The study provides a compelling rationale for targeting the oxidized mtDNA-ZBP1 axis. The success of TH10785 in reversing lethality even after the 8-hour NAC window suggests a potential new standard of care for late-presenting APAP overdose patients.
• Broader Implications: The mechanism of oxidation-driven Z-DNA formation may be relevant to other diseases involving oxidative stress and mitochondrial dysfunction, such as ischemia-reperfusion injury, neurodegenerative diseases, and aging.

Conclusion: The paper identifies a critical pathological axis where APAP-induced oxidative stress converts mitochondrial DNA into Z-DNA, which activates ZBP1 to trigger hepatocyte apoptosis. Targeting this axis via OGG1 activation offers a highly effective, potentially life-saving therapeutic strategy for drug-induced liver failure.